CoChat

Intracerebroventricular passive immunization with anti‐Aβ antibody in Tg2576

Chauhan, Neelima B., Siegel, George J. · 2003 · Journal of Neuroscience Research
Cited by 47

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Current Alzheimer's disease (AD) research has established the fact that excessive genesis of Aβ derived from amyloidogenic processing of β‐amyloid (Aβ) precursor protein is fundamental to AD pathogenesis. There has been considerable interest in using immunization strategies for clearing excessive Aβ. Studies in animal models of AD have shown that active immunizations or systemic passive immunizations reduced cerebral plaque load and improved behavioral deficits. However, clinical translation of an active immunization strategy was interrupted because of evidence for meningoencephalitis produced in some patients who received Aβ vaccine. Studies in animal models have shown perimicrovascular hemorrhages and inflammation after sustained systemic immunizations in animals with vascular amyloid. In this light, our data showing the effects of a single intracerebroventricular (ICV) injection of anti‐Aβ in the Alzheimer's Swedish mutant model Tg2576 are intriguing. We have previously demonstrated that a single ICV injection of anti‐Aβ into the third ventricle of 10‐month‐old Tg2576 mice reduced cerebral plaques, reversed Aβ‐induced depletion of presynaptic SNAP‐25, and abolished astroglial activation as seen 1 month post‐injection (Chauhan and Siegel [2002] J. Neurosci. Res. 69:10–23). The present report demonstrates that a single ICV injection of 10 μg anti‐Aβ in 10‐month‐old Tg2576 mice reduced cerebral plaques, with decreased inflammation at this stage as evidenced by a reduced number of interleukin‐1β‐positive microglia surrounding Congophilic plaques. Moreover, at this particular age, no microhemorrhage was discernible, as evidenced by the absence of hemosiderin deposition after a single ICV injection of anti‐Aβ. This is the first report demonstrating absence of microhemorrhage and reduced inflammation after the ICV introduction of anti‐Aβ in Tg2576 mice at 10 months of age. These facts indicate that, although invasive, ICV injection of anti‐Aβ may be a safer method of vaccination in AD, possibly through reducing the vascular exposure to antibody. Further studies are warranted to determine the lasting effects of a single ICV anti‐Aβ injection in animals with and without abundant plaque burden and at older ages. © 2003 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jnr.10721

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 47

Metadata

Authors
Chauhan, N. B., & Siegel, G. J.
Venue
Journal of Neuroscience Research
Publisher
Wiley
Published
2003-08-14
Volume
74
Issue
1
Pages
142-147
ISSN
  • 0360-4012 (ISSN-L)
  • 1097-4547
OpenAlex
W2006433483
Cited by
47
References
10
FWCI
4.34
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.